Gene · 353376
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology. | Front Cell Dev Biol | 2023 | 37941898 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. | Cell Commun Signal | 2023 | 37919729 | PubTator, text mining | PubMed |
| Tolerogenic dendritic cells and TLR4/IRAK4/NF-κB signaling pathway in allergic rhinitis. | Front Immunol | 2023 | 37915574 | PubTator, text mining | PubMed |
| The chemistry of gut microbiome-derived lipopolysaccharides impacts on the occurrence of food allergy in the pediatric age. | Front Mol Biosci | 2023 | 37900913 | PubTator, text mining | PubMed |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics. | Pharmaceutics | 2023 | 37896221 | PubTator, text mining | PubMed |
| The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. | JCI Insight | 2023 | 37870961 | PubTator, text mining | PubMed |
| Unraveling The Effects of DICER1 Overexpression on Immune-Related Genes Expression in Mesenchymal Stromal/Stem Cells: Insights for Therapeutic Applications. | Cell J | 2023 | 37865878 | PubTator, text mining | PubMed |
| Dihydroorotate dehydrogenase promotes cell proliferation and suppresses cell death in esophageal squamous cell carcinoma and colorectal carcinoma. | Transl Cancer Res | 2023 | 37859742 | PubTator, text mining | PubMed |
| The role of endotoxin in septic shock. | Crit Care | 2023 | 37858258 | PubTator, text mining | PubMed |
| Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. | Front Immunol | 2023 | 37822929 | PubTator, text mining | PubMed |
| Molecular pathways and nutrigenomic review of insulin resistance development in gestational diabetes mellitus. | Front Nutr | 2023 | 37799768 | PubTator, text mining | PubMed |
| Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways. | Front Immunol | 2023 | 37790926 | PubTator, text mining | PubMed |
| Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo. | Life Sci Alliance | 2023 | 37788908 | PubTator, text mining | PubMed |
| Outer membrane protein 25 of Brucella suppresses TLR-mediated expression of proinflammatory cytokines through degradation of TLRs and adaptor proteins. | J Biol Chem | 2023 | 37778729 | PubTator, text mining | PubMed |
| The functions and regulatory pathways of S100A8/A9 and its receptors in cancers. | Front Pharmacol | 2023 | 37701037 | PubTator, text mining | PubMed |
| Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis. | Am J Physiol Cell Physiol | 2023 | 37694283 | PubTator, text mining | PubMed |
| A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 37686291 | PubTator, text mining | PubMed |
| Role of toll-like receptors and nod-like receptors in acute lung infection. | Front Immunol | 2023 | 37662905 | PubTator, text mining | PubMed |
| IRF7: role and regulation in immunity and autoimmunity. | Front Immunol | 2023 | 37638030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/353376/papers?page=4